Mr.Charles Opoku|Regulatory Affairs|Best Researcher Award

Posted on by sciencefather

Mr.Charles Opoku|Regulatory Affairs|Best Researcher Award

Mr.Charles Opoku at Fiaseman Senior High School,Ghana

PROFILE  

ORCID

 

Early Academic Pursuits 📚

Charles Boateng Opoku embarked on his academic journey with a strong foundation in social sciences, obtaining a Bachelor of Arts degree in Economics and Geography from the University of Cape Coast in 2009. His undergraduate project, titled “Effectiveness of Community Development Programmes in Improving the Livelihoods of Rural Dwellers,” underscored his early commitment to understanding and improving local communities’ well-being. His studies not only provided a solid understanding of economics and geography but also fostered his desire to make meaningful contributions to development and economic planning.

Following this, he further honed his expertise by completing an MSc in Development Planning and Management at the Kwame Nkrumah University of Science and Technology (KNUST) between 2014 and 2017. His research during this time focused on the vulnerabilities of farm households in Ghana, particularly those affected by socio-economic shocks, in the Tarkwa-Nsuaem Municipality. This research highlighted his dedication to examining the dynamics of development and resilience in rural contexts, laying the groundwork for his subsequent professional and research endeavors. Currently, Opoku is pursuing a PhD in Planning at KNUST, focusing his research on the determinants of informal land market outcomes, which has significant implications for spatial planning and policy in Ghana.

Professional Endeavors 👔

Charles Opoku’s professional career has been marked by a blend of teaching, research, and fieldwork. Since 2011, he has served as an Economics Tutor at Fiaseman Senior High School in Tarkwa, where he has educated and inspired young students in the Western Region of Ghana. His impact extends into higher education as an Adjunct Lecturer at the University of Cape Coast’s College of Distance Education since 2018. There, he teaches various subjects, including Microeconomics, the Economy of Ghana, and Entrepreneurship, helping students build foundational skills and knowledge for their careers.

Additionally, Opoku has contributed significantly to data collection and analysis in Ghana through his roles with the Ghana Statistical Service. In 2023, he acted as a Center Lead and Regional Trainer for the Integrated Business Establishment Survey. He also held key roles during the 2021 Population and Housing Census, serving as both a Municipal Field Supervisor and National Trainer, where he contributed to the accurate collection of demographic and economic data critical to national planning.

Contributions and Research Focus 🔬

Charles Opoku’s research and professional work have centered on a range of crucial topics, including land use planning, human settlement planning, and development economics. His PhD research on informal land markets in Ghana addresses important aspects of spatial planning, a field of study that is critical for sustainable urban development. Through his thesis, Opoku seeks to provide insights into the often-overlooked informal land market sector and the ways it impacts effective planning, governance, and policy implementation.

He has also conducted research on urban resilience and the vulnerabilities faced by farm households, contributing valuable knowledge to the field of development planning. In his publication “Vulnerability and Responses of Farm Households to Socioeconomic Shocks: Evidence from Tarkwa-Nsuaem Municipality of Ghana,” Opoku explored the resilience strategies of rural communities against economic disruptions. His work in the area of rural women’s economic empowerment in Ghana has been particularly influential, with his publication in the Journal of Agricultural Extension and Rural Development examining the impact of the Rural Enterprise Program (REP) on economic self-sufficiency and empowerment in rural areas.

Accolades and Recognition 🏅

Throughout his career, Opoku has earned recognition for his academic achievements and professional dedication. His membership in the Ghana Institute of Planning as a Graduate Trainee signifies his status as an emerging expert in the field. Additionally, he is an active member of Ghana’s Monitoring and Evaluation Forum and the Association of Certified Chartered Economists (ACCE), both of which highlight his commitment to continued professional growth and excellence.

Impact and Influence 🌍

Opoku’s work has had a lasting impact on the communities he serves, especially through his contributions to Ghana’s educational sector and his involvement in national surveys. By educating high school and university students, he helps shape the next generation of economists and planners, fostering a culture of analytical thinking and social responsibility. His role in data collection and research has directly contributed to national projects, including the 2021 Population and Housing Census, where his leadership as a trainer ensured the accuracy and reliability of critical demographic data. This data serves as the basis for policy decisions, resource allocation, and development planning in Ghana, underscoring Opoku’s significant role in shaping his country’s socio-economic landscape.

Legacy and Future Contributions 🌱

Charles Opoku’s legacy will likely be one of dedicated service to both academia and public policy. His ongoing research in informal land markets aims to inform policy and promote sustainable spatial planning practices, which will benefit urban and rural areas in Ghana. As he completes his PhD, he is well-positioned to become a thought leader in urban and regional planning, contributing to policies that prioritize equitable land use and sustainable development.

Looking to the future, Opoku envisions expanding his research to include broader aspects of urban resilience and green economy strategies. His goal is to support the development of Ghanaian communities that are not only resilient to economic shocks but also environmentally sustainable. As he continues his teaching, research, and contributions to data collection, his work will undoubtedly inspire future economists, planners, and policymakers in Ghana and beyond. Through his multifaceted career, Charles Boateng Opoku exemplifies the impact of thoughtful planning, dedicated teaching, and rigorous research in advancing both community resilience and national development.

 

🎓Publication 

Critical factors impacting psychosocial well-being of mining-induced displaced and resettled persons in Ghana

  • Authors   : Charles Boateng Opoku; Jonathan Kwofie; Millicent Awo Pomma Asirifi
  • Year         :2024

Economic empowerment of rural women: Assessing the effectiveness of the rural enterprise program (REP) in Ghana, West Africa

  • Authors   :Zahra Nekoukar , Shahram Ala, Siavash Moradi, Andrew Hill, Ali Reza Davoudi Badabi, Ahmad Alikhani, Shahriar Alian, Minoo Moghimi, Amir Mohammad Shabani, Hamideh Abbaspour Kasgari
  • Journal    :Agricultural Extension and Rural Development
  • Year         :2022

Vulnerability and Responses of Farm Households to Socio-economic Shocks: Evidence from Tarkwa-Nsueam Municipality of Ghana

  • Authors   :Charles Boateng Opoku
  • Journal    : Innovative Research and Development
  • Year         :2020

 

Dr. Minoo Moghimi|Clinical Trials|Best Researcher Award

Posted on by sciencefather

Dr. Minoo Moghimi|Clinical Trials|Best Researcher Award

Dr. Minoo Moghimi at Mazandaran University of Medical Sciences,Iran

PROFILE  

Google scholar

 

Early Academic Pursuits 🎓

Minoo Moghimi embarked on her academic journey with a solid foundation in the National Organization for Development of Exceptional Talents, where she obtained her high school diploma in Yazd (2007-2011). This formative education laid the groundwork for her entrance into the field of pharmacy, where she pursued a PharmD at Yazd University of Medical Sciences from 2011 to 2018. Her early involvement with the faculty research committee highlighted her dedication to the field of pharmacotherapy, showcasing a keen interest in advancing pharmaceutical science right from the start.

Moghimi’s PharmD thesis focused on developing porous microencapsulated probiotics using a spray freeze drying technique. This innovative research emphasized the importance of drug formulation technology and aimed at enhancing probiotic viability. The success of this project led to a patent, marking a significant achievement in her early career and reflecting her capability to contribute meaningfully to pharmaceutical innovation.

Professional Endeavors 🏥

After completing her PharmD, Moghimi chose to channel her expertise into clinical applications by entering the Clinical Pharmacy Residency Program at Mazandaran University of Medical Sciences in 2018. This decision was driven by her passion for directly assessing drug effects in real-world patient scenarios. Throughout her residency, she demonstrated a profound dedication to clinical pharmacy, actively participating in research programs and engaging in numerous projects with a strong focus on clinical trials.

Her professional trajectory took a pivotal turn in 2020 during the COVID-19 pandemic when she contributed to the DISCOVER trial. This was a large-scale, randomized clinical trial involving over 1,000 patients, evaluating the efficacy of sofosbuvir and daclatasvir in treating hospitalized COVID-19 patients. The findings, published in the Journal of Antimicrobial Chemotherapy, were instrumental in understanding potential treatment options during the pandemic, reflecting her commitment to evidence-based clinical practice.

Moghimi’s professional expertise also extends beyond infectious diseases, as she has been involved in designing and implementing clinical trials in oncology, gynecology, and dentistry. Her diverse research portfolio underscores her adaptability and readiness to tackle multifaceted clinical challenges.

Contributions and Research Focus 📚

Minoo Moghimi’s primary research focus lies in managing chemotherapy-induced adverse effects, a critical area that significantly impacts cancer patient care. Her ongoing residency thesis, “Evaluation of the Efficacy and Safety of the Addition of Lacosamide to Duloxetine in the Treatment of Taxane-Induced Peripheral Neuropathy: A Randomized Double-Blind Placebo-Controlled Trial,” reflects this focus. Through this project, she aims to mitigate the debilitating side effects associated with chemotherapy, thus enhancing the quality of life for cancer patients.

In addition to her research in oncology, Moghimi has actively contributed to pharmacotherapy in critical care settings, clinical nutrition management, and drug-drug interaction management. Her ability to design comprehensive clinical trials is supported by her skills in clinical trial design, protocol development for critical medications, and medication reconciliation—skills that have proven vital in her multidisciplinary approach to patient care.

Moghimi’s contributions are not limited to clinical environments; she also engages in academic service. As a reviewer for respected journals like Pharmaceutical and Biomedical Research Journal (PBR) and Annals of Clinical and Medical Case Reports, she evaluates research, ensuring high standards in pharmacotherapy literature.

Accolades and Recognition 🏅

Throughout her academic and professional career, Minoo Moghimi has achieved several notable milestones. Her early achievement in patenting her thesis project during her PharmD studies reflects her commitment to innovation. During the COVID-19 pandemic, her role in the DISCOVER trial received significant recognition, as the study’s outcomes played a crucial role in informing clinical practices and treatment protocols for COVID-19 patients.

Impact and Influence 🌍

Minoo Moghimi’s research has had a tangible impact on the fields of clinical pharmacy and pharmacotherapy. Her work in chemotherapy-induced adverse effects, particularly taxane-induced peripheral neuropathy, aims to provide oncologists with better tools to manage the side effects of cancer treatments. By focusing on this critical aspect of cancer care, she is not only advancing research but also directly contributing to patient well-being, showcasing the transformative power of targeted pharmacotherapy.

Her involvement in critical care pharmacotherapy, nutrition management, and drug-drug interaction management demonstrates a holistic approach to patient care, where she considers various factors influencing therapeutic outcomes. This multidisciplinary expertise positions her as a key contributor to advancing patient-centered care in clinical settings.

Legacy and Future Contributions 🌟

Looking ahead, Minoo Moghimi aims to continue her work at the intersection of research and clinical practice. Her focus on chemotherapy-induced adverse effects, critical care, and nutrition management indicates a commitment to advancing patient care through evidence-based research. As a Board Certified Pharmacotherapy Specialist, her goal is to bridge the gap between research and clinical applications, ensuring that pharmacotherapy evolves in response to patient needs.

In the future, Moghimi plans to expand her research into novel drug therapies, aiming to develop innovative interventions for managing complex clinical conditions. Her dedication to the peer-review process reflects her intention to contribute to the scientific community by ensuring the dissemination of accurate and impactful research findings.

Skills and Technological Expertise 💻

Minoo Moghimi possesses a diverse skill set encompassing clinical trial design, research management, and critical care pharmacotherapy. Her expertise extends to protocol development for high-risk drugs, clinical nutrition, and drug-drug interaction management. In terms of technical skills, she is proficient with software like GraphPad Prism, Endnote, and MS Office—tools that are essential for managing data, conducting statistical analysis, and organizing research findings.

Research Interests and Aspirations 🔬

Her primary research interests revolve around chemotherapy-induced adverse effects, a field that holds immense potential for improving cancer care outcomes. Moghimi is also dedicated to critical care pharmacotherapy and nutrition management, fields where she hopes to make significant contributions in the future. Her aspiration is to develop strategies and guidelines that healthcare professionals can utilize to optimize treatment outcomes in complex clinical scenarios.

Conclusion 🎯

Minoo Moghimi’s journey from a dedicated pharmacy student to a Board Certified Pharmacotherapy Specialist is marked by a strong academic foundation, substantial research contributions, and a commitment to improving patient care. Her work has already left an indelible mark on the clinical pharmacy landscape, and her ongoing projects promise to further enhance therapeutic approaches in critical care and oncology. Moghimi’s career is a testament to the profound impact that dedicated research, clinical expertise, and a patient-centered approach can have in advancing healthcare.

🎓Publication 

A Narrative Review on Adverse Effects of Dasatinib With a Focus on Pharmacotherapy of Dasatinib-Induced Pulmonary Toxicities

  • Authors   :Zahra Nekoukar, Minoo Moghimi, Ebrahim Salehifar
  • Journal    :Blood Research
  • Year         :2021

Evaluation of the Effect of Sofosbuvir and Daclatasvir in Hospitalised COVID-19 Patients: A Randomized Double-Blind Clinical Trial (DISCOVER)

  • Authors   : Sara Mobarak, Mehdi Salasi, Ahmad Hormati, Javad Khodadadi, Masood Ziaee, Farshid Abedi, Azadeh Ebrahimzadeh, Zohreh Azarkar, Fariborz Mansour-Ghanaei, Farahnaz Joukar, Sara Yeganeh, Tofigh Yaghubi Kalurazi, Mohammadreza Naghipour, Zeinab Mehrabi, Amir Reza Bahadori, Shoeleh Yaghoubi, Rohollah Moslemi, Hamideh Abbaspour Kasgari, Hafez Fakheri, Minoo Moghimi, Amir Mohammad Shabani, Zahra Nekoukar, Farhang Babamahmoodi, 
  • Year         :2025

Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with moderate COVID-19, A

  • Authors   :Zahra Nekoukar , Shahram Ala, Siavash Moradi, Andrew Hill, Ali Reza Davoudi Badabi, Ahmad Alikhani, Shahriar Alian, Minoo Moghimi, Amir Mohammad Shabani, Hamideh Abbaspour Kasgari
  • Journal    :Iranian Journal of Pharmaceutical Research
  • Year         :2021

Suicide attempt using zinc phosphide rodenticide: A case report and literature review

  • Authors   :Zahra Nekoukar, Minoo Moghimi, Kimia Rasouli, Aref Hoseini, Zakaria Zakariaei, Rabeeh Tabaripour, Mahdi Fakhar, Elham Sadat Banimostafavi 
  • Journal    : Clinical case reports
  • Year         :2021

Prevalence of Thromboembolic Events, Including Venous Thromboembolism and Arterial Thrombosis, in Patients with COVID-19: A Systematic Review with Meta-Analysis

  • Authors   :Babak Bagheri, Abbas Alipour, Mojtaba Yousefi, Rozita Jalalian, Minoo Moghimi, Mahsa Mohammadi, Negar Hassanpour, Mohammadreza Iranian
  • Journal    :Tehran University of Medical Sciences
  • Year         :2023

Mr.Chunyuan Ping|Biopharmaceutics|Best Researcher Award

Posted on by sciencefather

Mr.ChunyuanPing|Biopharmaceutics|Best Researcher Award

Mr.Chunyuan Ping at Sichuan Toruism University,China

PROFILE  

 

Scopus

Early Academic Pursuits 📚

Chunyuan Ping’s academic journey began with a deep interest in the science of food processing and safety. After completing both Bachelor’s and Master’s degrees at the Henan Institute of Science and Technology, Ping honed a unique skill set in Agricultural Products Processing and Safety. This educational background offered a foundation in food science, which Chunyuan fortified with hands-on experience in food chemistry, sensory evaluation, and chemometrics. Through rigorous study and research, Ping developed expertise in critical methodologies like the Mantel test, statistical software such as Origin, SIMCA, and Design-Expert, and analysis tools including IBM SPSS, TBtools, and EndNote.

Professional Endeavors and Contributions 🔍🍲

Since 2022, Ping has been actively engaged in advanced research focusing on agricultural product processing, with a particular focus on volatile organic compounds (VOCs) and flavor chemistry. With a skillset in chemometric techniques, Ping has led several studies analyzing food products using High Sensitivity Gas Chromatography-Ion Mobility Spectrometry (HS-GC-IMS). In 2024, Ping published work in Food Chemistry: X, where the characteristic flavor quality of ceramic-pot sealed meat was evaluated post-reheating. This study utilized bionic sensory techniques combined with chemometrics to reveal the dynamic sensory attributes and chemical properties of this traditional culinary method, making substantial contributions to the field.

Ping’s expertise extends into multivariate statistics and sensory analysis, evidenced by research on Linjiangsi Broad Bean paste, where the effect of ripening time and fermentation environment on flavor profiles was examined. This project brought valuable insights into the traditional bean paste’s sensory characteristics and chemical profile. Another significant contribution was Ping’s study on high-temperature sterilization and pasteurization’s impact on volatile compounds in tomato stewed beef brisket, published in International Journal of Gastronomy and Food Science, advancing the understanding of processing techniques on flavor retention and modification.

Research Focus and Expertise 🎨🔬

Ping’s research interests lie in the interaction and degradation of volatile organic compounds within processed foods, specifically focusing on flavor profile preservation and enhancement. This focus has driven Chunyuan to conduct innovative studies on various traditional and modern processing techniques, using state-of-the-art tools like gas chromatography and multivariate analysis. Ping is particularly interested in how different sterilization methods, both thermal and nonthermal, influence flavor retention in complex dishes like lamp soup, with a master’s thesis dedicated to this topic.

Ping’s expertise in statistical and visual data representation has also significantly contributed to the ability to quickly produce high-quality figures and tables that support scientific claims and enhance research readability. This skill has proven instrumental in rapidly publishing in open-access (OA) journals, where effective data visualization is critical to reaching a broader scientific audience.

Accolades and Recognition 🌟🏅

Though still early in Ping’s career, the researcher’s work has already earned notable accolades in the field. Publications in high-impact journals, such as Food Chemistry: X and International Journal of Gastronomy and Food Science, showcase Ping’s scientific contributions and recognition among the academic community. These publications highlight Ping’s capability to independently conduct rigorous research and contribute significantly to food science literature. Additionally, the collaborative works listed, where Ping is often a co-author or a principal investigator, underscore Ping’s skill in teamwork and scientific communication, further establishing Ping’s reputation in agricultural and food chemistry research.

Impact and Influence 🌐📊

Ping’s research in food processing and safety has both immediate and far-reaching implications. By focusing on the preservation of flavor in prepared foods, Ping’s studies offer practical applications in the food industry, where maintaining flavor quality is paramount. The analyses conducted by Ping help streamline food processing techniques, making it possible to retain natural flavors without sacrificing food safety. These advancements contribute to the field by offering more sustainable and efficient methods, which benefit both industry professionals and consumers. Furthermore, the studies provide a reference point for future food safety research, potentially influencing policy in food processing standards.

Legacy and Future Contributions 🚀📈

Chunyuan Ping’s journey in the field of food science and safety is only beginning. Driven by a passion for exploring the complex interactions of VOCs and a keen interest in advancing food chemistry, Ping aspires to pursue a Ph.D. to gain more specialized knowledge and refine research methodologies. With a clear direction and an established foundation, Ping’s future work aims to provide actionable insights into the degradation and preservation of volatile compounds in processed foods. By continuing to publish and contribute to scientific literature, Ping is poised to become an influential figure in food science, especially in the field of flavor chemistry.

Through this ongoing research, Ping hopes to make lasting contributions that will not only advance scientific knowledge but also create a legacy of innovation within food chemistry and agricultural product processing. By enhancing methods of flavor preservation and quality control, Ping’s work could impact industry standards and contribute to healthier, better-tasting food products worldwide.

🎓Publication 

Evaluating the influence of high-temperature sterilization and pasteurization on volatile organic compounds in tomato stewed beef brisket: An analysis using gas chromatography-ion mobility spectrometry and multivariate statistical visualization

  • Authors   :Bi, J., Ping, C., Chen, Z., … Zhang, Y., He, H.
  • Journal    :International Journal of Gastronomy and Food Science
  • Year         :2024

Comparative study of volatile flavor compounds in green onion (Allium fistulosum L.) processed with different cooking methods

  • Authors   : Bi, J., Li, B., Chen, Z., … Zhang, Y., Zhang, L.
  • Journal    :International Journal of Gastronomy and Food Science
  • Year         :2024

Mining of kokumi peptides in chicken broth with peptidomics

  • Authors   :Li, Y., Bi, J., Lin, Z., … Ping, C., Chen, Z.
  • Journal    :International Journal of Gastronomy and Food Science
  • Year         :2023

Analysis of the effect of steaming times on lipid composition of pork belly based on lipidomics technology

  • Authors   :Bi, J., Li, Y., Yang, Z., … Ping, C., Chen, Z.
  • Journal    :Journal of Food Composition and Analysis
  • Year         :2023

Effects of different cooking methods on volatile flavor compounds in garlic

  • Authors   :Bi, J., Yang, Z., Li, Y., … Chen, Z., Li, C.
  • Journal    :International Journal of Gastronomy and Food Science
  • Year         :2023

Dr. John Thometz|Pharmaceutical Analysis|Excellence in Reach Award

Posted on by sciencefather

Dr.JohnThometz|Pharmaceutical Analysis|Excellence in Reach Award

Dr. John Thometz at Medical College of WI,United States

PROFILE  

 

Scopus

🏫 Early Academic Pursuits

Dr. John G. Thometz embarked on his academic journey in medical sciences with a strong foundation at Northwestern University, where he earned a Bachelor of Science in Medicine (B.S.M.) in 1973. His commitment to global understanding in medicine took him to Loyola University in Rome, Italy, where he furthered his education in 1974. Dr. Thometz then completed his medical degree (M.D.) at Northwestern Medical School in 1978, after which he was awarded a surgical scholarship at Addenbrooke’s Hospital in Cambridge, England. These experiences laid the groundwork for his illustrious career in orthopedic surgery, with a specialization in pediatric orthopedics.

🩺 Professional Endeavors

Dr. Thometz’s professional career began with intensive training, including a general surgery internship at Loyola University in Chicago, followed by a residency in orthopedic surgery at Northwestern University. His desire to make an impact in pediatric orthopedics led him to Harvard University’s Children’s Hospital, where he completed a fellowship in 1985. Soon after, he joined the Medical College of Wisconsin, where he served as Assistant Professor in the Department of Orthopaedic Surgery. Over the years, his dedication and expertise were recognized with progressive appointments, eventually reaching the rank of Professor in 2000. Dr. Thometz has also held a long-standing role as Adjunct Professor at Marquette University’s Orthopaedic and Rehabilitation Engineering Center (OREC), bridging academic and clinical disciplines.

🔬 Contributions and Research Focus

Dr. Thometz’s research has significantly advanced pediatric orthopedics, with a focus on developing innovative treatments and technologies for children with musculoskeletal disorders. His research spans early-onset scoliosis, cerebral palsy, and spinal deformities. His projects include contributions to critical studies on casting versus bracing in scoliosis treatment, funded by the Orthopaedic Research and Education Foundation (OREF), and a novel study on dynamic pedorthosis for clubfoot correction. In collaboration with the U.S. Department of Health and Human Services and the National Institute on Disability and Rehabilitation Research (NIDILRR), Dr. Thometz has led initiatives to train physicians and engineers in advanced pediatric rehabilitation.

🏅 Accolades and Recognition

Dr. Thometz’s dedication to orthopedic surgery has been widely recognized through numerous accolades, highlighting his commitment to excellence in both teaching and clinical practice. He was named Teacher of the Year twice by the Medical College of Wisconsin’s Department of Orthopaedic Surgery (1988, 2000) and awarded the prestigious Louis A. Goldstein Award for Best Clinical Poster Presentation at the 2010 Scoliosis Research Society Annual Meeting. His expertise has also earned him a consistent place on the Best Doctors in America list, as well as recognition by MKE Lifestyle Magazine for multiple years, underscoring his impact in Milwaukee and beyond.

🌍 Impact and Influence

Beyond his immediate clinical and teaching roles, Dr. Thometz has made substantial contributions to the orthopedic community nationally and internationally. He is an active member and fellow of esteemed organizations, including the American Academy of Orthopaedic Surgeons, the Pediatric Orthopaedic Society of North America, and the Scoliosis Research Society. His work in these societies has focused on advancing pediatric orthopedics and influencing guidelines on nonoperative management strategies, particularly in scoliosis care.

🏛️ Legacy and Future Contributions

As a pioneer in pediatric orthopedic surgery, Dr. Thometz has contributed to foundational research and mentorship that continue to shape the field. His leadership as Medical Director of Pediatric Orthopedic Surgery at the Children’s Hospital of Wisconsin spanned three decades, culminating in his role as Emeritus Medical Director for the Spina Bifida program. Dr. Thometz’s work on advanced rehabilitation technologies and orthopedic interventions continues through his position as Co-Program Director of the Advanced Rehabilitation Research Training (ARRT) in Pediatric Mobility. His legacy is further carried on by his students and residents, many of whom have become leaders in orthopedics. Dr. Thometz’s future contributions are poised to focus on guiding new research, particularly in enhancing pediatric mobility and rehabilitation, with a continued commitment to improving the quality of life for children globally.

🎓Publication 

Analysis of adolescent idiopathic scoliosis population for Surgical Site Infection Risk Factors

  • Authors   :Fletcher, J., Liu, X.-C., Thometz, J.G.
  • Journal    :Journal of Orthopaedics
  • Year         :2025

Correlation of transverse rotation of the spine using surface topography and 3D reconstructive radiography in children with idiopathic scoliosis

  • Authors   : Patel, M., Liu, X.-C., Tassone, C., … Yang, K., Thometz, J.
  • Journal    :Spine Deformity
  • Year         :2024

3D Back Contour Metrics in Predicting Idiopathic Scoliosis Progression: Retrospective Cohort Analysis, Case Series Report and Proof of Concept

  • Authors   : Patel, M., Liu, X.-C., Yang, K., … Escott, B., Thometz, J.
  • Journal    :Children,
  • Year         :2024

Prophylactic Spinal Cord Untethering in Children with Spinal Dysraphism Undergoing Thoracolumbar Fusion for Scoliosis

  • Authors   :Bureau, B.L., Sherburne, E., Thometz, J.G., Foy, A.B.
  • Journal    :World Neurosurgery
  • Year         :2023

Preoperative left shoulder elevation > 1 cm is predictive of severe postoperative shoulder imbalance in early onset idiopathic scoliosis patients treated with growth-friendly instrumentation

  • Authors   :Li, Y., Yang, D., Bergman, R., … Yazici, M., Zhang, T.J.
  • Journal    :Spine Deformity
  • Year         :2023

Dr. Annie Zhang|Immunotherapy|Best Researcher Award

Posted on by sciencefather

Dr. Annie Zhang|Immunotherapy|Best Researcher Award

Dr. Annie Zhang at Cambridge,United States

PROFILE  

 

Scopus

Dr. Annie Zhang embarked on her academic journey with a strong foundation in medicine and public health, earning an MD and an MPH. Her dual degrees equipped her with a nuanced understanding of clinical medicine and the critical public health frameworks essential for managing and preventing diseases at both population and individual levels. Driven by a commitment to advancing therapeutic options and improving patient outcomes, she honed her knowledge in both biostatistics and epidemiology. These skills have been foundational throughout her career, particularly in her roles focused on evidence generation and clinical research.

🌟 Professional Endeavors

Throughout her distinguished career, Dr. Zhang has held senior roles at prominent pharmaceutical companies, demonstrating her expertise in medical affairs, clinical research, and strategic evidence generation.

  1. Sanofi, Cambridge, MA
    As the Global Senior Medical Director in Immunology & Dermatology since 2018, Dr. Zhang has led impactful initiatives in Medical Evidence Generation within Global Medical Affairs. Her key achievements include winning Sanofi’s “Best of Best” award in 2023 and receiving a 1st Place Poster award at the American Academy of Dermatology (AAD) conference in 2024 for her work’s scientific importance. Her leadership has propelled Sanofi’s immunology initiatives, particularly through studies such as PEDISTAD and INFANTSTAD, which focus on disease modification and prevention of the atopic march.
  2. Apellis, Waltham, MA
    In her tenure as Medical Director at Apellis from January 2017 to December 2017, Dr. Zhang was responsible for strategic planning and clinical development in hematology, overseeing Phase II and III studies in conditions such as paroxysmal nocturnal hemoglobinuria (PNH) and autoimmune hemolytic anemia (AIHA). Her role included extensive interaction with thought leaders and the clinical team to design and optimize trial strategies.
  3. Biogen, Cambridge, MA
    From 2009 to 2016, Dr. Zhang held several pivotal roles at Biogen, advancing from Medical Director in Global Medical Affairs to leading biostatistical teams for key drug programs like Tecfidera. She worked on Tysabri’s lifecycle management, supporting clinical trial design, data generation, and publication strategies, especially in multiple sclerosis (MS). Her expertise in biostatistics and clinical research design strengthened Biogen’s data-driven approaches, particularly in Phase III and IV clinical trials.
  4. PAREXEL International, Lowell, MA
    Dr. Zhang worked as a Senior Biostatistician at PAREXEL from 2007 to 2009, leading biostatistical tasks across diverse therapeutic areas, including oncology, CNS disorders, and cardiovascular disease. Her meticulous approach ensured the quality and accuracy of statistical reports for clinical trials, contributing to numerous successful projects within the biostatistics team.
  5. New England Research Institutes, Watertown, MA
    Early in her career, Dr. Zhang served as an Associate Research Scientist at NERI from 2000 to 2007, where she conducted critical statistical analyses for clinical research, laying the groundwork for her later expertise in biostatistics and clinical study design.

💡 Contributions and Research Focus

Dr. Zhang’s research has centered around dermatology, immunology, and hematology. At Sanofi, her work in immunology has led to groundbreaking insights on skin barrier integrity and neuroimmune function, providing essential evidence for the prevention of atopic march. She has also driven significant advancements in real-world evidence generation, particularly in cross-functional collaboration with global market access and regulatory teams, demonstrating her strategic alignment with organizational goals and patient needs.

🏆 Accolades and Recognition

Dr. Zhang’s achievements have earned her numerous accolades, including the prestigious “Best of Best” award at Sanofi in 2023. In addition, she received 1st Place at the AAD 2024 Poster Award for her study on skin barrier health. Her work has also made her one of the most-read and cited authors in Allergy and Pediatric Dermatology in 2024, underscoring her impact and visibility in her field.

🌐 Impact and Influence

Through her extensive collaborations, Dr. Zhang has influenced clinical practices and regulatory frameworks worldwide. Her involvement in key study proposals and evidence generation initiatives has significantly impacted the medical community’s understanding of dermatological conditions. Her efforts in strategic planning, data generation, and cross-functional teamwork have positioned her as an influential figure in dermatology and immunology, particularly in advancing therapies that meet rigorous safety and efficacy standards.

🌱 Legacy and Future Contributions

Dr. Zhang’s legacy lies in her innovative approach to medical evidence generation and her unwavering commitment to patient-centered research. Her leadership in studies such as PEDISTAD and INFANTSTAD has set new standards for clinical research in dermatology and immunology. As she continues her work at Sanofi, Dr. Zhang’s contributions promise to expand the understanding and treatment of complex immunological conditions, impacting healthcare practices on a global scale.

Through her career, Dr. Zhang has exemplified excellence, dedication, and a strategic vision, ensuring her place as a respected leader in the pharmaceutical and clinical research sectors. Her ongoing work will undoubtedly continue to shape medical innovations and patient care improvements, leaving a lasting legacy in the fields of immunology and dermatology.

🎓Publication 

Efficacy and Tolerability of Delayed-release Dimethyl Fumarate in Black, Hispanic, and Asian Patients with Relapsing-Remitting Multiple Sclerosis: Post Hoc Integrated Analysis of DEFINE and CONFIRM

  • Authors   :Fox, R.J., Gold, R., Phillips, J.T., … Zhang, A., Marantz, J.L.
  • Journal    :Neurology and Therapy
  • Year         :2017

Number Needed to Treat in Multiple Sclerosis Clinical Trials

  • Authors   : Okwuokenye, M., Zhang, A., Pace, A., Peace, K.E.
  • Journal    :Neurology and Therapy
  • Year         :2017

Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis

  • Authors   : Fox, R.J., Chan, A., Zhang, A., … Edwards, M.R., Marantz, J.L
  • Journal    :Current Medical Research and Opinion
  • Year         :2017

Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies

  • Authors   :Gold, R., Giovannoni, G., Phillips, J.T., … Zhang, A., Marantz, J.L.
  • Journal    :Neurology and Therapy
  • Year         :2016

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS

  • Authors   :Spelman, T., Kalincik, T., Jokubaitis, V., … Trojano, M., Butzkueven, H.
  • Journal    :Neurology: Clinical Practice
  • Year         :2016

Prof Dr. Piotr Fiedor|Personalized Medicine|Best Researcher Award

Posted on by sciencefather

Prof Dr. Piotr Fiedor|Personalized Medicine|Best Researcher Award

Prof Dr. Piotr Fiedor at Department of General and Transplantation Surgery, Medical University of Warsaw,Poland

PROFILE  

 

Scopus

Early Academic Pursuits 🎓

Professor Piotr Fiedor, MD, PhD, embarked on his medical journey with a strong focus on surgery and transplantation. His academic pursuits began at Warsaw Medical University, where he completed his initial medical training. Earning both his MD and PhD, Fiedor developed a passion for complex medical fields such as transplantation immunology and biotechnology. During his early career, he broadened his expertise with international fellowships, notably at Columbia University in the United States, between 1993 and 1996, where he deepened his knowledge in transplantation immunology and immunomodulation. This fellowship solidified his expertise and set the stage for his contributions to both academia and the field of transplantation surgery.

Professional Endeavors 🔬

Professor Fiedor’s professional career has been a blend of clinical practice, research, and leadership roles. Since 1995, he has served in the Department of General and Transplantation Surgery at Warsaw Medical University. His responsibilities in this department include managing clinical procedures, conducting high-level research, and overseeing scientific programs. In addition to his academic role, Fiedor held the prestigious position of Chief Executive Officer at the National Medicine Institute in Warsaw from 2015 to 2017. During this period, he was responsible for overseeing the evaluation of medicinal products, ensuring high-quality standards, and coordinating with the European Directorate for the Quality of Medicines & HealthCare (EDQM).

Fiedor’s influence extends to regulatory affairs, particularly as the Polish Member of the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) from 2010 to 2017. His contributions in the CHMP involved acting as Rapporteur or Co-Rapporteur for more than 120 innovative medicinal products, ensuring their safe and effective use across Europe. His regulatory expertise continues, as he now serves as an Expert for the CHMP Scientific Advice Group.

Contributions and Research Focus 🧬

Professor Fiedor’s research has had a profound impact on the fields of transplant surgery, oncology, and immunology. His scientific work has addressed critical challenges in organ transplantation, including the immunological complications of transplants and strategies for improving graft survival. His work on the hemodynamic changes in organ donors before harvesting has been particularly influential, contributing to improved transplantation outcomes.

International collaborations have been a cornerstone of his research. He has worked with institutions like L’Aquila University in Italy, Columbia University and Ohio State University in the United States, and the Hebrew University of Jerusalem in Israel. His participation in 15 national scientific projects supported by Poland’s National Scientific Committee and two research grants from the National Institutes of Health (NIH) in the USA highlight his commitment to advancing medical science on a global scale.

Accolades and Recognition 🏅

Throughout his career, Professor Fiedor has received numerous awards recognizing his contributions to medical science, education, and public health. Some of his most notable honors include:

  • The Gold Cross of Merit awarded by the President of Poland in 2011 for his exceptional service to medicine.
  • The National Education Committee Medal in 2009 for his contributions to the advancement of medical education.
  • Multiple scientific awards from Warsaw Medical University, including team and individual awards for groundbreaking research on organ transplantation and immunology.
  • A notable achievement is his 2012 First-Degree Team Teaching Award from the Rector of Warsaw Medical University for co-authoring a textbook on disaster medicine.

These awards underline his influence on both medical practice and education.

Impact and Influence 🌍

Professor Fiedor’s impact extends beyond his clinical and research achievements. As a member of international organizations like the International Transplantation Society and the American Society of Transplant Surgeons (ASTS), he has helped shape the global discourse on transplant surgery and immunology. His work has led to significant advances in transplantation procedures, particularly concerning immunosuppressive therapies that reduce the risk of organ rejection.

In addition to his clinical and research accomplishments, Fiedor has played a vital role in shaping regulatory policies for medicinal products in Poland and Europe. His expertise in clinical trials, particularly through his work at the National Medicines Institute and his leadership in Good Clinical Practice (GCP) inspections, has influenced the standards of medical product approvals across Europe.

Legacy and Future Contributions 🌟

Professor Fiedor’s legacy lies in his multifaceted contributions to medicine. He has influenced generations of surgeons and medical professionals through his teaching roles at Warsaw Medical University. His over 210 scientific papers and 19 book chapters serve as valuable resources for both current and future medical researchers. His dedication to personalized medicine and biotechnology continues through his involvement in organizations such as the International Consortium for Personalized Medicine (IC PerMed), where he plays a role in advancing tailored healthcare solutions.

Looking forward, Fiedor’s ongoing work with European Joint Programs for Rare Diseases and the National Center for Research and Development’s Alpha Bridge Project ensures that he will continue to contribute to innovative research in the field of rare diseases and healthy society initiatives.

Conclusion 🔖

Professor Piotr Fiedor’s career stands as a testament to his dedication to the fields of surgery, immunology, and transplantation. With a rich history of academic achievements, clinical leadership, and regulatory expertise, his contributions have reshaped modern medicine, particularly in the realms of organ transplantation and medicinal product evaluation. His legacy continues to inspire both his peers and the next generation of medical professionals.

🎓Publication 

One Molecule, Many Faces: Repositioning Cardiovascular Agents for Advanced Wound Healing

  • Authors   : Gościniak, A., Stasiłowicz-Krzemień, A., Michniak-Kohn, B., Fiedor, P., Cielecka-Piontek, J.
  • Journal    :Molecules
  • Year         :2024

Are Current Educational and Therapeutic Programs, Directed at Rare Disease Transplant Candidates and Recipients, Sufficient to Support Them on the Path From Diagnosis to Life After Allogenic Transplantation?—Recommendations for Member State Policymakers

  • Authors   : Bartoszewicz, M., Prokop, P., Kosieradzki, M., Fiedor, P.
  • Journal    :Transplantation Proceedings
  • Year         :2024

Comparison of Long-Term Outcomes of Surgical Treatment of Human Papillomavirus-Dependent Neoplastic Lesions in Patients With Chronic Immunosuppression After Allogenic Organ Transplantation and Patients With Primary or Acquired Immunodeficiency—A One-Center Experience

  • Authors   : Prokop, P., Bartoszewicz, M., Gardyszewska, A., Kosieradzki, M., Fiedor, P.
  • Journal    :ransplantation Proceedings
  • Year         :2024

Amantadine in unvaccinated patients with early, mild to moderate COVID-19: A randomized, placebo-controlled, double-blind trial

  • Authors   :Rejdak, K., Fiedor, P., Bonek, R., … Kaczor, M., Grieb, P.
  • Journal    :European Journal of Neurology
  • Year         :2024

POLCOVID: a multicenter multiclass chest X-ray database (Poland, 2020–2021)

  • Authors   :Suwalska, A., Tobiasz, J., Prazuch, W., … Cieszanowski, A., Polanska, J.
  • Year         :2023

Prof. Satyanarayana Gedu|Pharmaceutical Chemistry|Best Researcher Award

Posted on by sciencefather

Prof.SatyanarayanaGedu|Pharmaceutical Chemistry|Best Researcher Award

Prof. Satyanarayana Gedu at Indian Institute of Technology Hyderabad,India

PROFILE  

orcid

Scopus

Dr. G. Satyanarayana’s academic journey began with a stellar performance during his undergraduate studies at Andhra University. From 1994 to 1996, he pursued a Bachelor of Science degree in Mathematics, Physics, and Chemistry (M.P.C), where he showcased exceptional talent, securing an impressive 87% and achieving first rank in his class. His academic excellence was acknowledged with a gold medal, symbolizing his hard work and dedication. His early focus on chemistry laid the foundation for a lifelong commitment to research in organic chemistry.

Following his undergraduate success, Dr. Satyanarayana pursued a Master of Science in Organic Chemistry from Andhra University from 1996 to 2001. He earned a first-class distinction with 70.5% marks, further solidifying his interest in organic chemistry. His strong foundation in organic chemistry and research potential set him on the path toward further academic achievements, ultimately leading him to a Ph.D. at the prestigious Indian Institute of Science (IISc) Bangalore.

Doctoral Research and Advanced Studies 🧑‍🔬

Dr. Satyanarayana embarked on his Ph.D. journey in 2001 under the guidance of Professor A. Srikrishna at the Indian Institute of Science. His research focused on organic synthesis, specifically the “Synthesis of (+)-Allopupukeanones, (–)-Valeriananoids and (±)-Herbertanes,” demonstrating his advanced understanding of complex organic compounds. By 2005, he successfully completed his doctoral work, earning recognition for his innovative approach and significant contributions to the field of organic synthesis.

Professional Endeavors and Global Exposure 🌍

Following his Ph.D., Dr. Satyanarayana’s academic career took him on an international trajectory. His postdoctoral research was shaped by prestigious fellowships and positions in renowned institutions. From December 2005 to November 2006, he worked as a Research Associate at the Department of Organic Chemistry, IISc Bangalore, before being awarded the Alexander von Humboldt (AvH) Postdoctoral Fellowship in 2006. This prestigious fellowship took him to the University of Tübingen, Germany, where he conducted advanced research in organic chemistry from February 2007 to June 2008.

Building on his international research experience, Dr. Satyanarayana then joined the University of Heidelberg in Germany as a Postdoctoral Research Fellow from October 2008 to September 2009. His time in Germany helped him gain valuable insights into cutting-edge organic chemistry research, broadening his expertise in synthesis and molecular structures.

Contributions and Research Focus 🔬

Dr. Satyanarayana’s primary research focus lies in the domain of organic synthesis, with a particular emphasis on the total synthesis of natural products. His work has contributed to advancements in synthetic methodologies, specifically in the creation of complex organic molecules. His research on the synthesis of Allopupukeanones, Valeriananoids, and Herbertanes, along with other compounds, showcases his expertise in designing novel synthetic routes, which have potential applications in pharmaceuticals and material science.

Throughout his career, Dr. Satyanarayana has published extensively in leading chemistry journals, contributing to the global body of knowledge in organic chemistry. His research not only highlights his dedication to expanding scientific understanding but also demonstrates the real-world implications of his work in industries such as drug discovery and development.

Accolades and Recognition 🏆

Dr. Satyanarayana’s exceptional contributions to academia and research have been widely recognized. Early in his career, he received a Junior Research Fellowship (JRF) from the Council for Scientific and Industrial Research (CSIR) in 2002, placing him among the top 20% of students in the nation. He also qualified for the Graduate Aptitude Test in Engineering (GATE) in 2001, securing an outstanding 98.47 percentile and earning an All India 28th rank.

His Ph.D. work at IISc earned him the coveted Gold Medal and Merit Certificate for Best Thesis in 2006, awarded by the Department of Organic Chemistry, IISc. This recognition was a testament to his innovative and impactful research contributions. Furthermore, he received the prestigious Alexander von Humboldt (AvH) Fellowship in 2006, which opened the door to further global research opportunities in Germany.

Over the years, Dr. Satyanarayana has been awarded multiple accolades for his excellence in teaching and research. In 2016 and 2020, he received the Best Teacher Award at IIT Hyderabad, highlighting his significant impact on students and the academic community. His outstanding achievements also earned him the Thieme Chemistry Journal Award in 2016, recognizing his contributions to the global chemistry community.

Impact and Influence on Academia and Research 📚

Dr. Satyanarayana’s influence extends beyond his research contributions. As a faculty member at the Indian Institute of Technology (IIT) Hyderabad, he has played a pivotal role in mentoring and shaping the next generation of chemists. His passion for teaching, coupled with his extensive research background, has made him a respected figure in the academic community. His commitment to guiding students in their academic and research pursuits has left a lasting impact on many budding chemists.

In addition to teaching, Dr. Satyanarayana’s research continues to inspire further investigations into organic synthesis and molecular chemistry. His innovative approaches and synthesis strategies serve as a reference point for researchers working on complex molecular synthesis worldwide.

Legacy and Future Contributions 🌱

Dr. Satyanarayana’s legacy is defined by his remarkable academic achievements, pioneering research, and unwavering dedication to education. His contributions to organic chemistry, particularly in the field of total synthesis, have paved the way for new discoveries in pharmaceuticals and material science. As he continues to mentor students and contribute to cutting-edge research at IIT Hyderabad, his work will undoubtedly inspire future chemists to push the boundaries of scientific exploration.

Looking ahead, Dr. Satyanarayana is poised to further enhance his impact on both the academic and research fields. With a strong foundation of accomplishments and recognition from global institutions, his future contributions will likely continue to shape the direction of organic chemistry research, making a lasting difference in science and society.

🎓Publication 

Electrochemical selenofunctionalization of unactivated alkenes: access to β-hydroxy-selenide

  • Authors   :Anil Balajirao Dapkekar; Gedu Satyanarayana
  • Journal    :Organic & Biomolecular Chemistry
  • Year         :2024

Electrochemical stereoselective borylation of Morita–Baylis–Hillman adducts to functionalized allylic boronates

  • Authors   :Jagadeesh Reddy Thondur; Duddu S. Sharada; Gedu Satyanarayana
  • Journal    :Chemical Communications
  • Year         :2024

Electrochemically driven regioselective construction of 4-sulfenyl-isochromenones from o-alkynylbenzoates and diaryl disulfides

  • Authors   : Anil Balajirao Dapkekar; Gedu Satyanarayana
  • Journal    :Organic & Biomolecular Chemistry
  • Year         :2024

Palladium catalyzed remote-meta-C–H functionalization of aniline scaffolds

  • Authors   : Dasari Srinivas; Gedu Satyanarayana
  • Journal    :Organic Chemistry Frontiers
  • Year         :2024

An acid-mediated synthesis of substituted naphthalenes from ortho-alkynyl tertiary benzylic alcohols

  • Authors   :Puja Singh; Sreenivasulu Chinnabattigalla; Komal Goel; Ravi Kishore Dakoju; Satyanarayana Gedu
  • Journal    :Tetrahedron
  • Year         :2024

Assoc Prof Dr. Shereen ElAzzazy|Oncology Pharmaceuticals|Best Researcher Award

Posted on by sciencefather

Assoc Prof Dr. Shereen ElAzzazy|Oncology Pharmaceuticals|Best Researcher Award

Assoc Prof Dr. Shereen ElAzzazy at HMC, QU, WHO,Qatar

PROFILE  

orcid

Google scholar

Early Academic Pursuits 🎓

The foundation of this individual’s career is rooted in a strong academic background. Although specific details about early education are not mentioned, the advanced roles undertaken in both pharmaceutical and medical sectors suggest a deep understanding and expertise in pharmacology, clinical pharmacy, and sterile medication preparation. Their professional journey likely began with formal education in pharmacy, complemented by continuous professional development and specialized training. The fact that they were entrusted with high-responsibility roles, such as acting pharmacy director, regulatory manager, and clinical instructor, indicates a robust educational foundation coupled with a commitment to lifelong learning.

Their association with the SAAD Training Institute, affiliated with Duke University, is an important academic highlight. This affiliation points to their exposure to global standards in pharmaceutical education and practices, which undoubtedly shaped their approach to teaching and developing competencies within their professional network.

Professional Endeavors 🏥

SAAD Specialist Hospital, Saudi Arabia (Dec 2003 – Jun 2006)
This phase of the career showcases the breadth and depth of their professional experience in Saudi Arabia’s healthcare system, particularly within SAAD Specialist Hospital, a prominent medical institution. Initially starting as a Pediatric Clinical Pharmacist in 2003, they quickly rose through the ranks to take on more senior and specialized roles.

  • Education and Development Coordinator (Dec 2005 – Jun 2006): In this role, they focused on the educational advancement of the hospital’s healthcare professionals. This position required overseeing staff training and ensuring adherence to the latest pharmaceutical guidelines and practices, fostering an environment of continual learning and improvement.
  • Aseptic Technology Instructor, SAAD Training Institute (Jun 2004 – Jun 2006): As an instructor, they were responsible for training both pharmacists and non-pharmacists in aseptic techniques, particularly in the preparation of sterile medications. The affiliation with Duke University highlights the high standard of education and training delivered.
  • IV Room Supervisor (Jun 2004 – Jun 2006): Managing the IV Room, they oversaw sterile medication preparation for neonates, pediatric, and adult patients, dealing with complex formulations such as Total Parenteral Nutrition (TPN), chemotherapy drugs, and desensitization protocols.

These roles reflect a strong command over clinical pharmacy, sterile practices, and pharmaceutical education, making them a critical contributor to healthcare improvement in Saudi Arabia.

Governmental Hospital of Tropical Diseases, Ministry of Health, Egypt (Dec 1997 – Dec 2003)
Their role at this governmental hospital in Egypt demonstrates significant leadership and management skills within the pharmaceutical services sector.

  • Inpatient Pharmacist (Dec 1997 – Sep 2002): During this period, they were entrusted with the pharmaceutical care of inpatient services, managing medication therapy and ensuring safe medication administration.
  • Acting Pharmacy Director (Oct 2002 – Dec 2003): As Acting Pharmacy Director, they assumed full authority over the hospital’s pharmacy operations. This role required balancing clinical duties with administrative responsibilities, overseeing drug inventories, ensuring compliance with pharmaceutical regulations, and leading the pharmacy staff.

This progression in Egypt’s healthcare sector speaks to their competence, leadership abilities, and the trust placed in them to manage essential healthcare operations.

CBIC Medical, Pharmaceutical Development, and Consultation Company (Nov 2002 – Dec 2003)
In parallel with their role in Egypt’s healthcare system, they also held a position in CBIC Medical, which involved regulatory and marketing responsibilities in the pharmaceutical sector.

  • Regulatory and Marketing Manager: They were tasked with navigating complex pharmaceutical regulations while overseeing the marketing of medical products. This role required a deep understanding of both the regulatory landscape and market dynamics.
  • Clinical and Marketing Instructor: Leveraging their extensive pharmaceutical knowledge, they conducted training programs for medical representatives, teaching them about new products and re-launched products, as well as imparting advanced marketing strategies.

This role illustrates their ability to work across both clinical and commercial spheres, bridging the gap between product development, regulatory compliance, and market outreach.

Contributions and Research Focus 🔬

While explicit research endeavors are not mentioned, their extensive work in teaching, sterile medication preparation, and regulatory roles highlights a career deeply rooted in evidence-based practices. Their focus on educating healthcare professionals in critical areas like aseptic techniques and sterile medication preparation indicates a dedication to improving healthcare outcomes through rigorous training.

The supervisory roles in sterile medication preparation, particularly for vulnerable populations such as neonates and pediatric patients, point to a keen interest in precision pharmacy and patient safety, areas likely to have been influenced by research in clinical pharmacology.

Accolades and Recognition 🏅

The trust and leadership roles assigned to them—ranging from being an Acting Pharmacy Director to a supervisor and instructor at the SAAD Specialist Hospital—reflect the high regard in which they were held by their peers and employers. Their instructional role at the SAAD Training Institute, affiliated with Duke University, is a significant marker of their expertise and the recognition they received in the field of pharmaceutical education.

Impact and Influence 🌍

Their influence spans multiple facets of healthcare, particularly in the realms of education, clinical pharmacy, and sterile medication practices. Through teaching roles, both at SAAD and CBIC Medical, they shaped the competencies of numerous healthcare professionals, directly impacting patient safety and care quality.

As a supervisor in the preparation of sterile medications, they ensured that some of the most vulnerable patients—neonates and those undergoing chemotherapy—received safe, effective treatments. This role would have had a profound impact on patient outcomes, underscoring their influence in clinical settings.

Legacy and Future Contributions 📜

Their legacy is marked by the high standards of training and education they provided, particularly in aseptic techniques and sterile medication preparation. The knowledge they imparted to medical representatives and pharmacy staff will continue to influence healthcare practices long after their direct involvement.

🎓Publication 

Patterns of onset and resolution of immune‐related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced …

  • Authors   :Jeffrey S Weber, Reinhard Dummer, Veerle de Pril, Celeste Lebbé, F Stephen Hodi, MDX010‐20 Investigators
  • Journal    : Cancer
  • Year         :2013

An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital

  • Authors   :Eva Rämme Bremberg, Christina Hising, Urban Nylén, Hans Ehrsson, Staffan Eksborg
  • Journal    :Journal of Oncology Pharmacy Practice
  • Year         :2006

The role of the pharmacist in the multidisciplinary approach to the prevention and resolution of drug-related problems in cancer chemotherapy

  • Authors   : Ahmet S Boşnak, Nevzat Birand, Ömer Diker, Abdikarim Abdi, Bilgen Başgut
  • Journal    :Journal of Oncology Pharmacy Practice
  • Year         :2019

Denosumab in hypercalcemia of malignancy: a case series

  • Authors   : Amanda Dietzek, Kelly Connelly, Michael Cotugno, Sylvia Bartel, Anne M McDonnell
  • Journal    :Journal of Oncology Pharmacy Practice
  • Year         :2015

Chinese herbal medicine for reducing chemotherapy-associated side-effects in breast cancer patients: a systematic review and meta-analysis

  • Authors   :Sha Li, Tsz-him So, Guoyi Tang, Hor-Yue Tan, Ning Wang, Bacon Fung Leung Ng, Chris Kam Wa Chan, Edwin Chau-Leung Yu, Yibin Feng
  • Journal    :Frontiers in Oncology
  • Year         :2020

Dr. Umang Shah| Medicinal Chemistry|Best Researcher Award

Posted on by sciencefather

Dr. Umang Shah|Medicinal Chemistry|Best Researcher Award

Dr. Umang Shah atRamanbhai Patel College of Pharmacy, CHARUSAT University,India

PROFILE  

orcid

Google scholar

Early Academic Pursuits 📘

Dr. Umang H. Shah’s educational journey has been a reflection of his consistent dedication to excellence. He laid a strong foundation during his schooling, achieving distinctions in both his S.S.C. and H.S.C. exams, with impressive percentages of 84.71% and 83.55%, respectively. His passion for the field of pharmaceutical sciences took root when he pursued his B. Pharm. degree from Shri B. M. Shah College of Pharmacy, affiliated with Hemchandracharya North Gujarat University, Patan. His academic performance remained stellar, securing 70% and graduating with distinction in 2005.

Further cementing his expertise in pharmaceutical chemistry, Dr. Shah pursued his M. Pharm. from The M. S. University of Baroda, Vadodara. Graduating in 2009 with 73.50% and a distinction, he demonstrated a growing passion for research and development in the pharmaceutical sector. Expanding his knowledge base, he also completed a Post Graduate Diploma in Patents Law from NALSAR Law University, Hyderabad, in 2012, which added a legal aspect to his pharmaceutical expertise.

Dr. Shah earned his Ph.D. in Pharmaceutical Chemistry from Charotar University of Science & Technology (CHARUSAT) in 2018, marking a significant academic milestone. His doctorate reflected years of hard work and dedication to advancing pharmaceutical research.

Professional Endeavors and Career Growth 📈

Dr. Shah’s career is a testament to his diverse experiences in both academia and the pharmaceutical industry. His first foray into the industry began in 2005, working as a Production Chemist at Swiss Parenterals Pvt. Ltd. and Marck Biosciences Ltd., where he honed his skills in drug production and manufacturing. His brief tenure as a Technical Supervisor at Cadila Pharmaceutical Ltd. from 2006 to 2007 further exposed him to the operational dynamics of large-scale pharmaceutical processes.

However, his true passion for education and research led him into academia. In 2009, he began his teaching career as a Lecturer at C. K. Pithawala Institute of Pharmaceutical Science & Research, where he stayed for two years. This experience fueled his desire to contribute to shaping the next generation of pharmacists and researchers. In 2011, Dr. Shah joined Ramanbhai Patel College of Pharmacy (RPCP), CHARUSAT, as an Assistant Professor. Over a span of more than a decade, he played a pivotal role in the academic and research development of the institution. By 2023, he had risen to the position of Associate Professor, a role he continues to excel in to date.

Contributions and Research Focus 🔬

Dr. Shah’s research contributions have left a significant mark on the field of pharmaceutical sciences, particularly in pharmaceutical chemistry. His research output includes 89 research and review publications in reputed national and international journals, making him a well-respected figure in the academic community. His work spans a wide range of areas, including drug synthesis, pharmaceutical formulations, and cell culture techniques, showcasing his interdisciplinary approach to research.

In addition to publications, Dr. Shah has presented over 20 papers at various conferences, further emphasizing his commitment to sharing his knowledge with the broader scientific community. His academic pursuits are not limited to journal publications; he has authored two books and contributed two chapters in Wiley publications, cementing his influence as an educator and researcher.

A mentor at heart, Dr. Shah has guided 11 M. Pharm students, helping them navigate their academic and research journeys. His impact extends beyond traditional academia, with his research garnering 6.2 lakh INR in grants from GUJCOST and 95,000 INR in SSIP grants. These grants have facilitated several innovative research projects under his supervision.

Dr. Shah’s expertise is also sought after in the field of consultancy, having completed 10 consultancy projects valued at INR 4,00,000, particularly in the area of cell culture techniques.

Accolades and Recognition 🏅

Dr. Shah’s career is decorated with numerous awards and honors. He has received 10+ national and international awards, recognizing his contributions to pharmaceutical education and research. His affiliations with prestigious organizations such as APTI, SPER, PRISAL, APP, and the MSU Alumni Association speak volumes about his standing within the professional community.

His academic impact is further highlighted by his active participation in professional societies, showcasing his commitment to staying at the forefront of the field.

Impact and Influence 🌍

Dr. Shah’s work has a wide-reaching impact both within India and internationally. His scholarly contributions, particularly his research publications and books, have advanced the understanding of pharmaceutical chemistry. His mentorship of students has not only contributed to their academic success but also shaped future leaders in the pharmaceutical industry.

Through his consultancy projects, Dr. Shah has contributed to real-world pharmaceutical applications, particularly in the specialized area of cell culture techniques, which are critical in drug development and testing.

Legacy and Future Contributions 🔮

As Dr. Shah continues his role as an Associate Professor, his legacy as an educator, researcher, and mentor is solidifying. His research outputs and publications will continue to serve as foundational references for future studies in pharmaceutical chemistry. Moreover, his ongoing work with students and researchers ensures that his influence will be felt for generations to come.

Looking ahead, Dr. Shah is expected to continue contributing to the field through innovative research projects, new academic publications, and further consultancy work. His commitment to pharmaceutical science, combined with his deep expertise in both the technical and legal aspects of the industry, positions him as a thought leader who will undoubtedly continue to make substantial contributions to the academic and pharmaceutical landscapes.

🎓Publication 

SYNTHESIS OF FLAVONES FROM 2-HYDROXY ACETOPHENONE AND AROMATIC ALDEHYDE DERIVATIVES BY CONVENTIONAL METHODS AND GREEN CHEMISTRY APPROACH

  • Authors   :UMANG SHAH SAMIR PATEL*
  • Journal    : Asian J Pharm Clin Res
  • Year         :2017

UV spectrophotometric and RP-HPLC methods for simultaneous estimation of isoniazid, rifampicin and piperine in pharmaceutical dosage form

  • Authors   :Umang Shah, Ankita Jasani
  • Journal    :International Journal of Pharmacy and Pharmaceutical Sciences
  • Year         :2014

A review on synthetic investigation for quinoline- recent green approaches

  • Authors   : Umang Shah, Ankita Jasani
  • Journal    :Green Chemistry Letters and Reviews
  • Year         :2022

A library of thiazolidin‐4‐one derivatives as protein tyrosine phosphatase 1B (PTP1B) inhibitors: an attempt to discover novel antidiabetic agents

  • Authors   : Ashish D Patel, Thopallada Y Pasha, Paras Lunagariya, Umang Shah, Tushar Bhambharoliya, Rati KP Tripathi
  • Journal    :ChemMedChem
  • Year         :2020

Chemometric Assisted Spectrophotometric Methods for Simultaneous Determination of Paracetamol and Tolperisone Hydrochloride in Pharmaceutical Dosage Form

  • Authors   : Ankita H. Jasani Umang H. Shah
  • Journal    :Eurasian Journal of Analytical Chemistry
  • Year         :2017

Dr. Jonathan Myers| Clinical Trials|Best Researcher Award

Posted on by sciencefather

Dr.JonathanMyers|Clinical Trials|Best Researcher Award

Dr. Jonathan Myers at VA Palo Alto Health Care System,United States

PROFILE  

orcid

scopus

Summary 🎉

Dr. Jonathan Myers is a distinguished Clinical Professor of Medicine at Stanford University, celebrated for his extensive contributions to exercise physiology and cardiovascular health. With over four decades of experience in academia and clinical research, his work has significantly advanced the field, particularly in exercise testing and rehabilitation for patients with cardiovascular diseases.

Education 🎓

Dr. Myers began his academic journey with a Bachelor of Arts in Ergonomics and Physical Education from the University of California, Santa Barbara in 1980. He pursued a Master’s in Exercise Physiology at San Diego State University in 1982 and completed his PhD at the University of Southern California in 1991. His educational foundation has profoundly influenced his research and clinical practices.

Professional Experience 🏥

Dr. Myers has held various prestigious positions, including Clinical Professor at Stanford University since 2008. His role as a Research Career Scientist for the Veterans Administration since 2004 underscores his commitment to improving veterans’ lives through innovative rehabilitation strategies. He has also served as a Clinical Associate and Assistant Professor at Stanford and directed the Exercise Research Laboratory at the Long Beach Veterans Affairs Medical Center.

Contributions and Research Focus 🔬

Dr. Myers has made significant contributions to exercise physiology, particularly in cardiopulmonary exercise testing and cardiac rehabilitation. His research focuses on the physiological responses to exercise in various populations, including those with cardiovascular diseases, diabetes, and spinal cord injuries. He has played a key role in developing guidelines for exercise testing and prescription, influencing clinical practices globally.

Accolades and Recognition 🏆

Dr. Myers has received numerous awards, including the Citation Award from the American College of Sports Medicine (2021) and the Distinguished Professor Award from the Mexican Society of Cardiac Rehabilitation (2021). His accolades reflect his leadership and dedication to enhancing exercise science.

Impact and Influence 🌍

Dr. Myers’ influence extends beyond academia into public health and clinical practice. As a member of various organizations and committees, he has shaped policies advocating for the integration of exercise in healthcare. His involvement in the Healthy Living for Pandemic Event Protection (HL-PIVOT) Network emphasizes the importance of exercise in public health strategies.

Legacy and Future Contributions 🔮

Looking ahead, Dr. Myers aims to continue his research in exercise physiology, focusing on the needs of diverse populations, particularly in chronic diseases and rehabilitation. His dedication to mentorship and teaching will inspire the next generation of exercise physiologists. Dr. Myers remains committed to advocating for the critical role of physical activity in maintaining health and preventing disease, leaving a legacy of innovation and unwavering support for improving quality of life through exercise.

🎓Publication 

Impact of Cardiorespiratory Fitness on COVID-19–Related Outcomes: The Exercise Testing and Health Outcomes Study (ETHOS)

  • Authors   :Peter Kokkinos; Cristina Cadenas-Sanchez; Angelike Liappis; Carl J. Lavie; Navjit K. Goraya; Amy Weintrob; Andreas Pittaras; Alexandros Ladas
  • Journal    : Mayo Clinic Proceedings
  • Year         :2024

Analysis of Demographic and Socioeconomic Factors Influencing Adherence to a Web-Based Intervention Among Patients After Acute Coronary Syndrome: Prospective Observational Cohort Study (Preprint)

  • Authors   :Biagio Sassone; Giuseppe Fuca’; Mario Pedaci; Roberta Lugli; Enrico Bertagnin; Santo Virzi’; Manuela Bovina; Giovanni Pasanisi; Simona Mandini; Jonathan 
  • Journal    :Preprint
  • Year         :2024

 

Hypertension and Ventilatory Responses During Exercise in the Fitness Registry and the Importance of Exercise National Database (FRIEND)

  • Authors   :  Joseph C. Watso; Austin T. Robinson; Ross Arena; Matthew P. Harber; Leonard A. Kaminsky; Jonathan Myers
  • Journal    :The Journal of Infection in Developing Countries
  • Year         :2024

Analysis of Demographic and Socioeconomic Factors Influencing Adherence to a Web-Based Intervention Among Patients After Acute Coronary Syndrome: Prospective Observational Cohort Study

  • Authors   : Biagio Sassone; Giuseppe Fuca’; Mario Pedaci; Roberta Lugli; Enrico Bertagnin; Santo Virzi’; Manuela Bovina; Giovanni Pasanisi; Simona Mandini; Jonathan
  • Journal    :JMIR Cardio
  • Year         :2024